Pu'er Propaganda Department and National People's Congress to Yunnan Peak for Investigation
Release time:
2021-03-12
News from our newspaper # February 26 , 3# June 4 , relevant leaders of Pu 'er Municipal Party Committee Propaganda Department and Pu 'er Municipal People's Congress successively went to Yunnan Jianfeng Cement Company to conduct research on the management of the enterprise, future development ideas, mining and other topics. 2# November
26During the survey, Wang Hongbin, member of the Standing Committee of the Pu'er Municipal Committee and Minister of Propaganda, fully affirmed Yunnan Jianfeng, as a key leading enterprise and major taxpayer in Pu'er City, for its contribution to the economic development of Pu'er. Appreciation for the scientific prevention and control of Yunnan's peak during the new coronary pneumonia epidemic, reasonable organization of production, sales volume and economic and technical indicators; and hope that Yunnan peak can continue to dig deep potential, increase investment in technological transformation, and strive to achieve greater development. In response to some problems encountered in the current enterprise development process, Wang Hongbin said that the municipal party committee and the municipal government will, based on the actual situation, urge relevant functional departments to speed up and come up with reasonable plans to solve the worries of enterprise development. 3 June
4, a delegation from Pu 'er City and Simao District People's Congress led by Qin Yongxun, deputy director of Pu 'er City People's Congress, went to Yunnan Jianfeng to learn about mine design, mining and reclamation. Liu Shenghua, general manager of Yunnan Jianfeng, made a report on the recent mining and management, and conducted on-site docking and discussion with representatives of relevant functional departments on some specific problems encountered during the period. Qin Yongxun said that Yunnan Jianfeng is the benchmark for mining enterprises in Pu'er City. In the follow-up work, we must adhere to the equal emphasis on ecology and benefits, and do a good job in the connection between "green water and green mountains" and "golden mountains and silver mountains"; Pu'er City is formulating mine management regulations and hopes Yunnan Jianfeng Put forward opinions and suggestions from the actual situation of the enterprise, help relevant departments formulate management measures scientifically, and promote the improvement of local mine management level. (Zhao Yuqian)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31